Aurinia to Host Annual General Meeting of Shareholders and Webcast on June 21 in Vancouver, BC

VICTORIA, British Columbia--()--Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”) today announced that the Company will be hosting its Annual General Meeting of Shareholders at 9 a.m. (Pacific Time) in Vancouver, BC.

An audio webcast can be accessed under "News/Events” through the “Investors” section of the Aurinia corporate website at www.auriniapharma.com. A replay of the webcast will be available on Aurinia’s website.

About Aurinia

Aurinia is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The Company is currently developing voclosporin, an investigational drug, for the treatment of LN. The Company is headquartered in Victoria, BC and focuses its development efforts globally. www.auriniapharma.com

Contacts

Aurinia Pharmaceuticals Inc.
Investors:
Celia Economides
Vice President, Public Affairs
ceconomides@auriniapharma.com

Recent Stories

RSS feed for Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc.